NO168706C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.

Info

Publication number
NO168706C
NO168706C NO863139A NO863139A NO168706C NO 168706 C NO168706 C NO 168706C NO 863139 A NO863139 A NO 863139A NO 863139 A NO863139 A NO 863139A NO 168706 C NO168706 C NO 168706C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
heterocyclic substituted
substituted benzamides
analogy procedure
Prior art date
Application number
NO863139A
Other languages
English (en)
Other versions
NO168706B (no
NO863139D0 (no
NO863139L (no
Inventor
Armando Vega Noverola
Jose Manuel Prieto Soto
Fernando Pujol Noguera
Robert Geoffrey Willi Spickett
Jacinto Moragues Mauri
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of NO863139D0 publication Critical patent/NO863139D0/no
Publication of NO863139L publication Critical patent/NO863139L/no
Publication of NO168706B publication Critical patent/NO168706B/no
Publication of NO168706C publication Critical patent/NO168706C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO863139A 1985-08-06 1986-08-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider. NO168706C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519707A GB8519707D0 (en) 1985-08-06 1985-08-06 Chemical compounds

Publications (4)

Publication Number Publication Date
NO863139D0 NO863139D0 (no) 1986-08-04
NO863139L NO863139L (no) 1987-02-09
NO168706B NO168706B (no) 1991-12-16
NO168706C true NO168706C (no) 1992-03-25

Family

ID=10583372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863139A NO168706C (no) 1985-08-06 1986-08-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.

Country Status (28)

Country Link
US (1) US4772618A (no)
EP (1) EP0213775B1 (no)
JP (1) JPH0662614B2 (no)
KR (1) KR920001763B1 (no)
CN (1) CN1022830C (no)
AR (2) AR243521A1 (no)
AT (1) ATE49206T1 (no)
AU (1) AU596110B2 (no)
CA (1) CA1300154C (no)
DD (1) DD287502A5 (no)
DE (1) DE3667975D1 (no)
DK (1) DK370586A (no)
EG (1) EG18154A (no)
ES (2) ES2000705A6 (no)
FI (1) FI89168C (no)
GB (1) GB8519707D0 (no)
GR (1) GR862060B (no)
HU (1) HU201060B (no)
IE (1) IE58751B1 (no)
IL (1) IL79469A0 (no)
MX (1) MX3375A (no)
MY (1) MY101352A (no)
NO (1) NO168706C (no)
NZ (1) NZ217078A (no)
PH (1) PH25019A (no)
PL (1) PL150228B1 (no)
PT (2) PT83146B (no)
ZA (1) ZA865537B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JP2999669B2 (ja) * 1993-08-24 2000-01-17 株式会社三和化学研究所 ベンゾ［ｂ］フランカルボキサミド誘導体、その製法及び用途
JPH0820586A (ja) 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
JPH0873463A (ja) * 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
CN1052228C (zh) * 1996-01-17 2000-05-10 中国科学院大连化学物理研究所 N-甲酰基哌啶及其同系物的制备方法
CN1091104C (zh) * 1998-04-02 2002-09-18 中国科学院大连化学物理研究所 一种n－甲酰基哌啶的制备方法
JP4145872B2 (ja) 2002-06-11 2008-09-03 あき電器株式会社 自転車の前照灯及び前照灯電気回路
EP1704146B1 (en) * 2004-01-07 2010-04-14 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
WO2012028614A1 (en) * 2010-09-01 2012-03-08 Janssen Pharmaceutica Nv 5-ht2b receptor antagonists
CN110950843B (zh) * 2019-11-28 2022-12-27 广东东阳光药业有限公司 取代的苯酰胺衍生物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1019781A (no) 1963-03-05
US3342826A (en) 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
GB1507462A (en) * 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives

Also Published As

Publication number Publication date
FI89168B (fi) 1993-05-14
MY101352A (en) 1991-09-05
JPH0662614B2 (ja) 1994-08-17
AU596110B2 (en) 1990-04-26
AR243521A1 (es) 1993-08-31
IE862073L (en) 1987-02-06
IL79469A0 (en) 1986-10-31
CN86105972A (zh) 1987-04-01
ATE49206T1 (de) 1990-01-15
NO168706B (no) 1991-12-16
PT83147B (pt) 1988-07-29
EP0213775B1 (en) 1990-01-03
JPS62129279A (ja) 1987-06-11
DD287502A5 (de) 1991-02-28
ES2000706A6 (es) 1988-03-16
EG18154A (en) 1992-11-30
ZA865537B (en) 1987-03-25
PL150228B1 (en) 1990-05-31
KR920001763B1 (ko) 1992-03-02
MX3375A (es) 1993-12-01
US4772618A (en) 1988-09-20
PL260921A1 (en) 1988-01-07
DK370586D0 (da) 1986-08-04
AU6075886A (en) 1987-02-12
GB8519707D0 (en) 1985-09-11
NO863139D0 (no) 1986-08-04
CN1022830C (zh) 1993-11-24
FI89168C (fi) 1993-08-25
IE58751B1 (en) 1993-11-03
AR242793A1 (es) 1993-05-31
DK370586A (da) 1987-03-27
HU201060B (en) 1990-09-28
PT83146B (pt) 1988-07-29
CA1300154C (en) 1992-05-05
GR862060B (en) 1986-12-24
DE3667975D1 (en) 1990-02-08
FI863179A0 (fi) 1986-08-04
KR870002071A (ko) 1987-03-28
EP0213775A1 (en) 1987-03-11
NZ217078A (en) 1989-01-27
NO863139L (no) 1987-02-09
PT83147A (en) 1986-09-01
FI863179A (fi) 1987-02-07
HUT44782A (en) 1988-04-28
ES2000705A6 (es) 1988-03-16
PH25019A (en) 1991-01-28
PT83146A (en) 1986-09-01

Similar Documents

Publication Publication Date Title
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO168706C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO865148L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO862676L (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme benzamider.
NO172386C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
NO168581C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer
NO159444C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetylamin-derivater.
NO162820C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolpyridin- eller benzimidazolderivater.